GlassScriptPhysician profile
Amir Toor
NPI 1902883176
$925.94
in general payments reported to CMS, 2019-2025
7 companies · $35.50 in 2025
The $35.50 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $216 · 2022: $19.99 · 2023: $212 · 2024: $292 · 2025: $35.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285 · Education: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.98 |
| Education | $254.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $254.64 | 2023-2024 | |
| Genzyme Corporation | $213.11 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $153.22 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2023 | Calquence |
| Astellas Pharma US INC | $124.74 | 2024 | Xospata |
| Boston Scientific Corporation | $35.50 | 2025 | Watchman Flx |
| Kite Pharma, INC. | $19.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Toor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.